v3.25.2
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]                    
Loans $ 5,167,574 $ 5,728,237 $ 5,829,057 $ 5,933,158 $ 6,103,592 $ 6,253,435 $ 6,339,422 $ 6,326,924    
Allowance for credit losses on loans (111,204) (151,067) (155,443) (160,844) (159,319) (157,815) (151,415) (140,864) $ (128,889) $ (89,444)
Total loans, net 5,056,370 5,577,170 5,673,614 5,772,314 5,944,273 6,095,620 6,188,007 6,186,060    
Accrued interest receivable 25,329 35,037 34,115   34,133          
Credit enhancement asset 16,804 20,633 18,202 16,369 15,389 15,111 14,720 13,959    
Other assets 208,839 187,643 209,923 197,051 199,886 240,559 192,225 174,467    
Total assets 7,506,809 7,704,189 7,708,074 7,763,708 7,790,046 7,893,109 7,961,296 7,861,789 7,793,066  
Accrued interest payable and other liabilities 124,266 103,481 103,487 102,827 110,377 106,704        
Total liabilities 6,795,962 6,932,968 6,971,295 7,040,664 7,074,933 7,211,636        
Retained earnings 247,698 287,484 276,029 259,302 245,639 234,324 234,463 226,815    
Total shareholders’ equity 710,847 771,221 736,779 723,044 715,113 681,473 703,396 707,258 696,139 600,190
Total liabilities and shareholders’ equity $ 7,506,809 7,704,189 7,708,074 7,763,708 7,790,046 7,893,109 7,961,296 7,861,789    
As Previously Reported                    
Error Corrections and Prior Period Adjustments Restatement [Line Items]                    
Loans   5,748,819 5,851,994 5,958,462 6,131,079 6,280,883 6,367,344 6,354,271    
Allowance for credit losses on loans   (85,804) (92,183) (78,057) (68,502) (66,669) (64,950) (62,067)    
Total loans, net   5,663,015 5,759,811 5,880,405 6,062,577 6,214,214 6,302,394 6,292,204    
Accrued interest receivable   27,099 25,756   24,934          
Credit enhancement asset   0 0 0 0 0 0 0    
Other assets   177,663 199,487 182,201 182,992 222,966 175,821 160,272    
Total assets   7,751,483 7,757,274 7,831,809 7,866,868 7,969,285 8,034,721 7,930,174    
Accrued interest payable and other liabilities   103,737 103,694 102,966 110,459 106,743        
Total liabilities   6,933,224 6,971,502 7,040,803 7,075,015 7,211,675        
Retained earnings   334,522 325,022 327,264 322,379 310,461 307,888 295,200    
Total shareholders’ equity   818,259 785,772 791,006 791,853 757,610 776,821 775,643 758,574 663,837
Total liabilities and shareholders’ equity   7,751,483 7,757,274 7,831,809 7,866,868 7,969,285 8,034,721 7,930,174    
Adjustment                    
Error Corrections and Prior Period Adjustments Restatement [Line Items]                    
Loans   (20,582) (22,937) (25,304) (27,487) (27,448) (27,922) (27,347)    
Allowance for credit losses on loans   (65,263) (63,260) (82,787) (90,817) (91,146) (86,465) (78,797)    
Total loans, net   (85,845) (86,197) (108,091) (118,304) (118,594) (114,387) (106,144)    
Accrued interest receivable   7,938 8,359   9,199          
Credit enhancement asset   20,633 18,202 16,369 15,389 15,111 14,720 13,959    
Other assets   9,980 10,436 14,850 16,894 17,593 16,404 14,195    
Total assets   (47,294) (49,200) (68,101) (76,822) (76,176) (73,425) (68,385)    
Accrued interest payable and other liabilities   (256) (207) (139) (82) (39)        
Total liabilities   (256) (207) (139) (82) (39)        
Retained earnings   (47,038) (48,993) (67,962) (76,740) (76,137) (73,425) (68,385)    
Total shareholders’ equity   (47,038) (48,993) (67,962) (76,740) (76,137) (73,425) (68,385) $ (62,435) $ (63,647)
Total liabilities and shareholders’ equity   $ (47,294) $ (49,200) $ (68,101) $ (76,822) $ (76,176) $ (73,425) $ (68,385)